• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗人群中高血压、血脂异常和糖尿病的知晓率、治疗率和控制率:IHHP 研究。

Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study.

机构信息

lsfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran.

出版信息

East Mediterr Health J. 2009 Nov-Dec;15(6):1455-63.

PMID:20218138
Abstract

We used data from the baseline survey from the Isfahan Healthy Heart Programme to determine the prevalence of hypertension, dyslipidaemia and diabetes among a representative samples of 12,514 adults living in 3 cities in the Islamic Republic of Iran. The prevalence of hypertension, dyslipidaemia and diabetes was 17.3%, 66.3% and 5.6% respectively. Awareness, treatment and control of hypertension were 40.3%, 35.3%, and 9.1% respectively. The rates for dyslipidaemia were 14.4%, 7.1% and 6.5% respectively, and 54.6% of diabetics were aware of their disease and 46.2% were under treatment.

摘要

我们利用伊朗伊斯兰共和国三个城市中 12514 名成年人的基线调查数据,确定了高血压、血脂异常和糖尿病在代表性样本中的流行率。高血压、血脂异常和糖尿病的流行率分别为 17.3%、66.3%和 5.6%。高血压的知晓率、治疗率和控制率分别为 40.3%、35.3%和 9.1%。血脂异常的发生率分别为 14.4%、7.1%和 6.5%,54.6%的糖尿病患者知晓自己的疾病,46.2%的糖尿病患者正在接受治疗。

相似文献

1
Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study.伊朗人群中高血压、血脂异常和糖尿病的知晓率、治疗率和控制率:IHHP 研究。
East Mediterr Health J. 2009 Nov-Dec;15(6):1455-63.
2
Prevalence of hypertension and associated risk factors in Isfahan, Islamic Republic of Iran.伊朗伊斯兰共和国伊斯法罕的高血压患病率及相关危险因素
East Mediterr Health J. 1999 Sep;5(5):992-1001.
3
Association of diabetes mellitus and dyslipidaemias in the Tehran population.德黑兰人群中糖尿病与血脂异常的关联。
East Mediterr Health J. 2008 May-Jun;14(3):647-53.
4
Clustering of coronary artery disease risk factors in patients with type 2 diabetes and impaired glucose tolerance.2型糖尿病和糖耐量受损患者冠状动脉疾病危险因素的聚集情况。
East Mediterr Health J. 2008 Sep-Oct;14(5):1080-9.
5
Evaluation of awareness of diabetes mellitus and associated factors in four health center areas.四个健康中心区域糖尿病知晓情况及相关因素评估
Patient Educ Couns. 2006 Jul;62(1):142-7. doi: 10.1016/j.pec.2005.06.018. Epub 2005 Sep 1.
6
[Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population].[中国中年人群高血压患病率、知晓率、治疗率及控制率的变化趋势]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):407-11.
7
Cardiovascular risk prevalence, awareness, treatment, and control from 1998 to 2007 in Koreans.1998年至2007年韩国人心血管疾病风险的患病率、知晓率、治疗率及控制率
Asia Pac J Clin Nutr. 2010;19(2):261-5.
8
A comparison of knowledge of diabetes mellitus between patients with diabetes and healthy adults: a survey from north Malaysia.糖尿病患者与健康成年人对糖尿病知识的比较:来自马来西亚北部的一项调查。
Patient Educ Couns. 2007 Dec;69(1-3):47-54. doi: 10.1016/j.pec.2007.06.017. Epub 2007 Aug 27.
9
Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009.2007 至 2009 年加拿大成年糖尿病患者中高血压的流行率、知晓率、治疗率和控制率。
Can J Cardiol. 2012 May;28(3):367-74. doi: 10.1016/j.cjca.2011.08.111. Epub 2012 Jan 26.
10
Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.有心肌梗死和中风病史的非住院患者心血管疾病危险因素的患病率、知晓率、治疗率和控制率的趋势。
Am J Epidemiol. 2006 May 15;163(10):913-20. doi: 10.1093/aje/kwj124. Epub 2006 Apr 5.

引用本文的文献

1
Rationale, Design, and Initial Findings of Community Trial on Improving the Iranian's Knowledge and Practice of Dyslipidemia Management, Prevention, and Control.关于提高伊朗人血脂异常管理、预防和控制知识与实践的社区试验的原理、设计与初步结果
ARYA Atheroscler. 2022 Jun;18(6):2727. doi: 10.48305/arya.2022.16303.2727. Epub 2022 Dec 1.
2
How Similar Are Drug Data and Disease Self-report? Estimating the Prevalence of Chronic Diseases in Less Developed Settings.药物数据和疾病自我报告有多相似?在欠发达地区估算慢性病的患病率。
Arch Iran Med. 2024 Jul 1;27(7):364-370. doi: 10.34172/aim.27553.
3
Validation of the self-reported diagnosis of diabetes mellitus, hypercholesterolemia, and hypertension in Iran; STEPS 2016.
伊朗2016年成人健康危险因素监测调查中自我报告的糖尿病、高胆固醇血症和高血压诊断的验证
J Diabetes Metab Disord. 2024 Jan 3;23(1):745-758. doi: 10.1007/s40200-023-01344-9. eCollection 2024 Jun.
4
The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies.2022 年全球糖尿病意识、治疗和控制的趋势:233 项代表性人群研究的系统评价和荟萃分析。
Front Public Health. 2024 May 17;12:1305304. doi: 10.3389/fpubh.2024.1305304. eCollection 2024.
5
Update of the clinical guideline for hypertension diagnosis and treatment in Iran.伊朗高血压诊断与治疗临床指南的更新
Clin Hypertens. 2024 Jun 1;30(1):13. doi: 10.1186/s40885-024-00269-6.
6
An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996-2023.一项关于伊朗 1996 年至 2023 年 2 型糖尿病患病率的更新系统评价和荟萃分析。
Front Public Health. 2024 Apr 4;12:1322072. doi: 10.3389/fpubh.2024.1322072. eCollection 2024.
7
Awareness of Hypertension, Hypercholesterolemia, and Diabetes Mellitus and Associated Characteristics in Russian Adults.俄罗斯成年人对高血压、高胆固醇血症和糖尿病的知晓情况及相关特征
Int J Hypertens. 2024 Mar 25;2024:8542671. doi: 10.1155/2024/8542671. eCollection 2024.
8
Awareness of the diagnosis, treatment, and control of diabetes mellitus in Brazil.巴西民众对糖尿病的诊断、治疗和控制的认知情况。
Rev Saude Publica. 2023 Nov 3;57:75. doi: 10.11606/s1518-8787.2023057005167. eCollection 2023.
9
Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021.基于 STEPS 调查 2021 年的数据评估伊朗的糖尿病照护环节和对世界卫生组织全球覆盖目标的遵循情况。
Sci Rep. 2023 Aug 19;13(1):13528. doi: 10.1038/s41598-023-39433-7.
10
Relationship between knowledge and adherence to hypertension treatment.高血压治疗知识与依从性之间的关系。
J Public Health Afr. 2023 Mar 16;14(Suppl 1):2502. doi: 10.4081/jphia.2023.2502. eCollection 2023 Mar 30.